Posts by: Ashraf Malhas, PhD

News

A Phase 2 clinical trial determined that treatment with dalantercept, an inhibitor of blood vessel maturation, is safe but has limited effectiveness in ovarian cancer patients, none of whom responded to the ... Read more

February 7, 2018February 7, 2018

Antidepressant Use Does Not Increase Epithelial Ovarian Cancer Risk, Analysis Reveals

News

Women taking antidepressants are not at increased risk for epithelial ovarian cancer, according to a large-scale analysis of eight studies. While a combination of multiple studies is the best approach to ... Read more

December 11, 2017

Higher Levels of Tumor T-cells Predict Better Survival Rates in Certain Ovarian Cancer Patients, Study Finds

News

The levels of certain white blood cells in tumors correlate with longer overall survival in patients with some types of epithelial ovarian cancer, regardless of first-line chemotherapy or the extent ... Read more

November 20, 2017November 20, 2017

New Drug Discovery Program Identifies Potential Treatments for Ovarian Cancer, Other Diseases

News

Researchers have developed a new computer program, known as DrugPredict, to find new therapeutics for unmet diseases, like ovarian cancer, among medications the U.S. Food and Drug Administration (FDA) has already ... Read more

October 16, 2017October 16, 2017

First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery

News

The pharmaceutical development company NanOlogy has enrolled the first participant in its Phase 2 trial evaluating the safety and effectiveness of NanoPac, a new delivery method for the anti-cancer treatment ... Read more